semaglutide binge eating disorder case report GLP-1 Agonist for Disorder: Evidence and Safety Semaglutide-associated worsening of atypical anorexia

In accordance with the classical model of food intake control GLP-1 action on feeding has been primarily ascribed to receptor populations in the hypothalamus and the hindbrain

Several plausible mechanisms may explain why some patients experience body aches or muscle soreness while taking Zepbound, even in the absence of a direct pharmacological cause

doi:10.1016/S2213-8587(19)30068-3 11

They both work in similar ways, but tirzepatide has been shown to be more effective in reducing weight and body fat

When dose schedules, monitoring, and tailored nutrition are added, the same drug produces not only better metrics, but also less anxiety and fewer stop-start cycles

54 The delivery of MSC with intravenous, intramuscular, or intranasal for the treatment of neurodegenerative disease is still debatable